Evofem Takes Aim At Preventing Pregnancy And STIs With Amphora
Executive SummaryEvofem Biosciences is preparing for Phase III trials for Amphora, an on-demand contraceptive that has surpassed Phase II endpoints in preventing bacterial sexually transmitted infections.
You may also be interested in...
Keeping Track Of Thanksgiving Leftovers: Risdiplam, Artesunate Highlight Glut Of Submissions/Filings
Yes, we know they should be out of the fridge by now, but here are the highlights of submissions and filings during the Thanksgiving week.
The latest drug development news and highlights from our FDA Performance Tracker.